Exercise Your Amyloid  by Karsten, Stanislav L. & Geschwind, Daniel H.
Cell
572
Nikolaidou, K.K., and Barrett, K. (2005). Trends Genet. 21, 70–73.coordinately control these two pathways of cytoskele-
Schmidt, A., and Hall, A. (2002). Genes Dev. 16, 1587–1609.tal regulation. Indeed, these investigators identified a
Tahinci, E., and Symes, K. (2003). Dev. Biol. 259, 318–335.mechanism of crossregulation in this system. First, they
determined that RIC1 inhibits the ability of the ROPs to Wallingford, J.B., Fraser, S.E., and Harland, R.M. (2002). Dev. Cell
2, 695–706.promote actin MFs. Thus, disruption of RIC1 results in
increased MFs while overexpression of RIC1 inhibits
MF assemble. Moreover, RIC1 overexpression antago-
nized the ROP2-RIC4 interaction in a spatially con-
trolled manner, consistent with a regulatory scheme in
which shared GTPase effectors antagonize each other.
However, a simple mechanism involving competitive in-
teractions between these two effectors with a common
ROP GTPase was ruled out, and instead it was demon-
strated that RIC1’s ability to antagonize the ROP-RIC4
interaction depends on its ability to promote MTs. Thus,
disruption of MTs leads to increased ROP-RIC4 interac-
tion. The mechanism by which MTs regulate ROP-RIC4
remains to be established.
Overall, these findings reveal a fascinating mecha-
nism of crosstalk between GTPase-mediated signaling
pathways that functions to coordinate cytoskeleton-
dependent morphogenesis in plants. The proposed
ROP-mediated pathways appear to account for the for-
mation of spatially distributed lobes and indentations
within individual leaf cells. However, the mechanism by
which adjacent cells communicate such that the in-
dentations of one cell are aligned with the lobes of its
neighbor remains unclear. Moreover, the nature of up-
stream signals that regulate the spatially localized acti-
vation of the ROPs in pavement cells has yet to be
established. Presumably, the guanine nucleotide ex-
change factors (GEFs), which function to activate small
GTPases, play an important role (Schmidt and Hall,
2002). In other systems, subcellularly localized activa-
tion of small GTPases has been linked to spatially dis-
tributed GEF activity, and the activation of at least
some GEFs results from their direct association with
cell surface receptors. Thus, it is possible that adjacent
pavement cells communicate via spatially distributed
cell surface receptors and corresponding ligands to
transduce signals to the ROP GTPases that coordinate
their alignment. Future studies that further elucidate the
upstream and downstream components of this GTPase
network will undoubtedly reveal an elaborate mecha-
nism of coordinated tissue morphogenesis that poten-
tially extends from developing plant leaves to gastrulat-
ing vertebrates.
Jeffrey Settleman
MGH Cancer Center and Harvard Medical School
Charlestown, Massachusetts 02129
Selected Reading
Baum, B. (2004). Curr. Biol. 14, R716–R718.
Fu, Y., Li, H., Yang, Z., Jones, M.A., Shen, J.J., and Grierson, C.S.
(2002). Plant Cell 14, 777–794.
Fu, Y., Gu, Y., Zheng, Z., Wastenys, G., and Yang, Z. (2005). Cell
120, this issue, 687–700.
Keller, R. (2002). Science 298, 1950–1954.
Keller, R., Davidson, L., Edlund, A., Elul, T., Ezin, M., Shook, D., and
Skoglund, P. (2000). Philos. Trans. R. Soc. Lond. B Biol. Sci. 355,
897–922.DOI 10.1016/j.cell.2005.02.025
Exercise Your Amyloid
The interplay of genetics and the environment in the
etiology of Alzheimer’s disease (AD) is not well
understood. Now, Lazarov and coworkers (Lazarov et
al., 2005 [this issue of Cell]) show that a simple para-
digm of environmental enrichment alleviates amyloid
burden and alters disease-associated gene expres-
sion changes in a double transgenic mouse model
of AD.
Most AD patients suffer from nonmendelian forms of
AD, in which the interaction of multiple genes with the
environment leads to neurodegeneration. Even so, the
identification of mendelian (single gene) forms of AD
has permitted the generation of animal models in which
specific aspects of the molecular pathogenesis of AD,
as well as targeted interventions, can be studied. In this
issue of Cell, Lazarov and coworkers demonstrate that
simple alterations in the environment of male APP/PS1
transgenic mice, which carry two distinct, highly pene-
trant, dominantly acting human disease-causing al-
leles, result in a remarkable decrease of cerebral Aβ
peptides and amyloid deposits in vivo. The authors also
use microarrays to identify reproducible gene expres-
sion changes in mutant mice placed in an enriched en-
vironment, compared with control mice. Standard en-
richment paradigms were used, consisting of 3 hr
periods of exposure to a cage containing running
wheels, colored tunnels, and various toys, first daily fol-
lowed by several months of 3 days per week exposure.
Using a stepwise microarray analysis of hippocampal
tissues from several cohorts of animals, 41 genes were
identified and verified as differentially regulated in re-
sponse to an enriched environment; some of these
genes had been previously implicated as neuroprotec-
tive in the APPswe mouse model. To address by what
molecular means the environment may be acting, La-
zarov et al. also show that among some of the gene
expression changes is the enhancement of Aβ degra-
dation mechanisms in the CNS of “enriched” animals.
In particular, the activity of neprilysin (NEP), an amyloid-
degrading enzyme (Iwata et al., 2000), is markedly ele-
vated in the brains of “enriched” mice.
How any animal model translates to human disease is
always a thorny issue and models for AD are certainly no
exception. However, these important results are placed in
appropriate context by numerous clinical and epidemio-
logic studies in humans that support the notion of an in-
dividual’s innate or acquired cognitive “reserve” delaying
dementia or age-related cognitive decline (for review
see Buckner, 2004). Several longitudinal studies have
explored the effect of educational attainment, occupa-
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573tion, social network, and physical exercise on demen-
tia, and a positive effect on cognition was suggested
for all of these components (for review see Fratiglioni
et al., 2004). Studies in humans suffer from a chicken or
egg dilemma: is it the exercise or education that delays
deterioration or a common genetic predisposition that
builds a brain that is more resistant to the ravages of
aging, while at the same time producing a more en-
gaged and active intellect? This work by Lazarov and
colleagues provides relevant genetic and functional
data supporting a potentially causal inverse relation-
ship between a more engaging, enriched life and AD
progression in an animal model with remarkable un-
derlying genetic risk for disease. These data parallel
previous observations in a model of Huntington’s dis-
ease, in which environmental enrichment was also
shown to delay disease progression (e.g., van Dellen et
al., 2000)
Of course, we really do not know how the life of a
caged mouse translates into the various levels of edu-
cational attainment, occupational status, as well as
other intellectual, social, and physical aspects of daily
human life in relation to AD progression. Standard
mouse housing conditions resemble the natural envi-
ronment of a wild mouse very little. If “enrichment” is
similar to the normal environment then perhaps stan-
dard housing conditions are synonymous with depriva-
tion. It may be rather the poor or “deprived” environ-
ment that predisposes to neurodegeneration and
inhibits the natural neuroprotective mechanisms of a
more active lifestyle. In this context, Lazarov and col-
leagues do show that even within the enriched group,
those animals with higher levels of physical activity
show the most significant reduction in amyloid burden.
However, this result is only correlative since the animals
were not randomly assigned to a given amount of exer-
cise and animals with less disease/amyloid burden may
be inclined to exercise more.
Nevertheless, even considering alternate interpre-
tations, these experiments demonstrate that brief
periods of deviation from the normal environment can
alter Aβ production and deposition. This raises several
essential questions: is there an effect on behavior, cog-
nition, or survival, and if so, what are the molecular
mechanisms involved in the correction of phenotype?
No doubt that one of the most challenging tasks in this
area is to identify regulatory factors underlying the
adaptations and subsequent neuroprotection following
environmental enrichment. Since the pro-proliferative
effect of exercise and the enriched environment on
neural stem cells has been well demonstrated (van
Praag et al., 1999), perhaps it is activity-induced neuro-
genesis that underlies the striking effects observed
either directly, by increased production of neprilysin, or
indirectly by other means. If so, blocking neurogenesis
or growth factors known to mediate this activity-
induced proliferation should increase amyloid burden.
At a simpler level, the contribution of newly born cells
to neprilysin activity changes, or the other changes in
gene expression observed, can be directly investigated
anatomically or by laser-capture microdissection at the
level of individual cell classes. The role of neurogenesis
and other factors, such as stress modulation, metabolic
balance (caloric intake or restriction), etc. can now beaddressed, especially given potential clues from the as-
sociated gene expression signature identified in this
study.
Although Aβ is clearly a defining feature of AD, it also
must be recognized that the relationship between Aβ
plaques and clinical progression in AD remains contro-
versial. A direct relationship between amyloid deposi-
tion and neuronal loss has yet to be convincingly dem-
onstrated (e.g., Takeuchi et al., 2000). In contrast, the
connection between tau pathology, synaptic loss, and
cognitive decline in AD is more direct (e.g., Terry et al.,
1991). Still, amyloid burden increases with disease pro-
gression, and the clearance of amyloid in animal mod-
els has resulted in clinical and pathological ameliora-
tion in these models (reviewed in Tanzi et al., 2004).
Thus, the extent to which environmental manipulation
affects synaptic loss and its accompanying behavioral
and cognitive decline in this model are critical remain-
ing questions. Other doubly transgenic mouse models
carrying mutated PS1 and APP develop extensive neu-
rofibrillary tangle (NFT) pathology, and environmental
effects on NFT accumulation, subsequent neuronal
loss, cognition, and mortality will be crucial to estab-
lish. Similarly, it will be important to test the environ-
mental repair paradigm used by Lazarov et al. in other
single- or multi-gene models of neurodegeneration, so
as to truly understand the generalizability of these
findings.
Like many other potentially important observations in
science, the study by Lazarov et al. raises more ques-
tions than it can answer—in doing so, it provides some
clear initial directions for exploring the role of the envi-
ronment and the molecular pathways perturbed in AD
and other neurodegenerative disorders. For example,
what is the timecourse of these changes, and are they
stable over a prolonged period? An equally important
issue is to what extent do the changes in gene expres-
sion observed with enrichment in a mutant animal re-
present a pseudonormalization of aberrant gene ex-
pression to values present in control, nontransgenic
mice? This highlights another important aspect of this
work: the identification of biomarkers related to disease
status or pathological status. Normalization of disease-
associated gene expression patterns could represent a
powerful indicator of disease progression. The molecu-
lar signatures identified by microarray provide potential
therapeutic targets and a set of biomarkers that can be
explored in humans (Geschwind, 2003) or used to fol-
low a particular aspect of disease progression in model
organisms. Such biomarkers are likely to provide far
more tangible and more proximal therapeutic endpoints
than chronic changes in clinical status in human thera-
peutic trials.
We dedicate this preview to the memory of our co-
worker, Zheng Luo.
Stanislav L. Karsten and Daniel H. Geschwind
Program in Neurogenetics
Department of Neurology
David Geffen School of Medicine
UCLA
Los Angeles, California 90095
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